BAMCO Inc’s Tandem Diabetes Care TNDM Stock Holding History

BAMCO Inc’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-121,615	Closed	-$7.2M	–	379
2022 Q2	$7.2M	Buy	+121,615	New	+$9.98M	0.02%	264

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BAMCO Inc's TNDM Position: Q3 2022 in Review

BAMCO Inc sold out of Tandem Diabetes Care (TNDM) in Q3 2022, closing a stake of 121,615 shares — an estimated $7.2M sold.

BAMCO Inc first reported a position in TNDM in Q2 2022 and held it in 1 quarter. The position peaked at $7.2M in Q2 2022. 299 funds tracked by Wall St. Rank hold TNDM as of Q3 2022.

BAMCO Inc reported no remaining Tandem Diabetes Care position as of Q3 2022 after selling out during the quarter.
BAMCO Inc sold 121,615 Tandem Diabetes Care shares in Q3 2022, an estimated $7.2M.
BAMCO Inc first reported a position in Tandem Diabetes Care in Q2 2022 and held it in 1 quarter.
BAMCO Inc's Tandem Diabetes Care position peaked at $7.2M in Q2 2022.
299 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2022.

Based on BAMCO Inc's 13F filing for Q3 2022, filed 14 Nov 2022.